Please assess the completion status of the following clinical trial:

Trial Title: A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female aged 18-65 years (both inclusive)~* Type 1 diabetes mellitus (as diagnosed clinically) for at least 12 months~* Body mass index 18.0-28.0 kg/m\^2 (both inclusive)~Exclusion Criteria:~* Subject who has donated any blood or plasma in the past month or more than 500 mL within 3 months prior to screening~* Smoker (defined as a subject who is smoking more than 5 cigarettes or the equivalent per day)~* Not able or willing to refrain from smoking and use of nicotine gum or transdermal nicotine patches during the inpatient period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- IDeg (Type: EXPERIMENTAL): None
- IGlar (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).